tiprankstipranks
Trending News
More News >
Editas Medicine Inc (EDIT)
NASDAQ:EDIT
Advertisement

Editas Medicine (EDIT) Similar Stocks

Compare
3,523 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Editas Medicine
$4.08
$353.39M
30.77%
5 Buy
5 Hold
2 Sell
Hold
Cellectis SA
$4.17
$323.56M
108.50%
0 Buy
1 Hold
0 Sell
Hold
Foghorn Therapeutics
$4.42
$254.38M
-37.39%
3 Buy
0 Hold
0 Sell
Strong Buy
Elicio Therapeutics
$10.52
$171.88M
130.69%
2 Buy
0 Hold
0 Sell
Moderate Buy
Vor Biopharma
$33.40
$231.23M
136.72%
2 Buy
0 Hold
0 Sell
Moderate Buy
Caribou Biosciences
$2.68
$249.57M
52.78%
6 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
EDIT
Editas Medicine
4.08
1.12
37.84%
CLLS
Cellectis SA
4.17
2.17
108.50%
FHTX
Foghorn Therapeutics
4.42
-2.64
-37.39%
ELTX
Elicio Therapeutics
11.05
6.26
130.69%
VOR
Vor Biopharma
31.72
18.63
142.32%
CRBU
Caribou Biosciences
2.75
0.95
52.78%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis